Logo.png
IMUNON’s Chief Science Officer to Present at the 3rd International Vaccines Congress
October 23, 2023 08:30 ET | Imunon, Inc.
Highlights advantages of IMUNON’s PlaCCine modality over current commercial vaccines LAWRENCEVILLE, N.J., Oct. 23, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage...
LOGO.jpg
Celsion Corporation Announces Time of Oral Presentation at International Vaccines Congress
October 15, 2021 09:00 ET | Celsion CORP
Chief Science Officer Dr. Khursheed Anwer to Deliver Virtual Presentation Monday, October 18 at 7:30 a.m. Eastern Time LAWRENCEVILLE, N.J., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation...
LOGO.jpg
Celsion Corporation Announces Oral Presentation at International Vaccines Congress
October 12, 2021 09:00 ET | Celsion CORP
Chief Science Officer Dr. Khursheed Anwer to Deliver Virtual Presentation on Celsion’s Ongoing Work with DNA-based Vaccines LAWRENCEVILLE, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Celsion...